High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.0M
$1,016,138
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TBPH
S
Theravance Biopharma, Inc.
Farnum Rhonda
• Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
2026-03-16
$108,088
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
|
2026-03-16 | $108,088 | S | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
Farnum Rhonda
• Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
2026-03-16
$217,476
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
|
2026-03-16 | $217,476 | S | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
Farnum Rhonda
• Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
2026-03-16
$108,073
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
|
2026-03-16 | $108,073 | S | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
Farnum Rhonda
• Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
2025-12-03
$145,630
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
|
2025-12-03 | $145,630 | S | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
Farnum Rhonda
• Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
2025-12-03
$145,619
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
|
2025-12-03 | $145,619 | S | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
Farnum Rhonda
• Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
2025-12-03
$291,252
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
|
2025-12-03 | $291,252 | S | Form 4 |